Concepedia

Min Hye Noh

MH

Statistics

Publications

5

Citations

86

H-Index

5

Active since

2017

Affiliations

Inje University Busan Paik Hospital(Current)

Inje University

Min Hye Noh is an author at Inje University Busan Paik Hospital specializing in pharmacology, oncology, and erlotinib therapy.

ORCID

Publications per year

2017–2024

5

Publications

5

Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway

Seungwoo Hong, Nam‐Sook Park, Min Hye Noh et al. · Lung Cancer · 2017 · 25 citations

, , +10

Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy

Min Hye Noh, Jin Muk Kang, Alexandra Miller et al. · Neuro-Oncology · 2024 · 22 citations · Full text

, , +17

Erlotinib Activates Different Cell Death Pathways in EGFR-mutant Lung Cancer Cells Grown in 3D<i>Versus</i>2D Culture Systems

Hyun-Kyung Lee, Min Hye Noh, SEUNG-WOO HONG et al. · Anticancer Research · 2021 · 15 citations · Full text

, , +17

Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells

Sung Ho Moon, Nam‐Sook Park, Min Hye Noh et al. · Anticancer Research · 2021 · 13 citations

, , +17

Celecoxib upregulates ULBP‑1 expression in lung cancer cells via the JNK/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicity

Jayoung Kim, Min Hye Noh, Dae Young Hur et al. · Oncology Letters · 2020 · 11 citations · Full text

, , +10

1–5 of 5